This content is machine translated Lung cancer Lung cancer in focus: What’s new? Overall survival of patients with lung cancer has increased by approximately 15% over the past decade. This is primarily due to new therapeutic options, including targeted drugs. However, in order…
View Post 4 min This content is machine translated Long-COVID “The first two months are still considered a grace period”. Many patients complain of persistent symptoms after they have recovered from SARS-CoV-2 infection. In such cases, the first path usually leads to the family doctor, but the armamentarium available to…
View Post 3 min This content is machine translated Anti-infectives Recognize and adequately treat COVID-19 associated aspergillosis. Corona is not alone in having respiratory problems. Invasive pulmonary aspergillosis may also be clustered – usually very rapidly. Therefore, increased attention to this clinical picture is required, especially in…
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health. Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
View Post 15 min This content is machine translated Pediatric pneumology Growing up after lung transplantation Lung transplantation (Lutx) is also an established therapeutic option in childhood and adolescence when, despite exhaustion of all available therapeutic measures, a severe disease progresses, quality of life is significantly… CME-Test
View Post 4 min This content is machine translated Non-small cell lung cancer The first targeted therapy for KRAS G12C mutation [1]. After decades of effort, it is now possible for the first time to provide patients with KRAS G12C-mutated non-small cell lung cancer with an effective targeted therapy [1,2]. In the…
View Post 5 min This content is machine translated "Folie à deux" Infections are a frequent trigger of venous thromboembolism Acute infections activate various inflammatory and procoagulant mechanisms and are considered transient risk factors for venous thromboembolism (VTE). Infections not associated with bed rest and hospitalization also increase the risk…
View Post 5 min This content is machine translated Severe asthma Personalized asthma management with biologics as an add-on treatment option Patients with asthma can nowadays be treated well, even in severe forms, if they are given the individually appropriate treatment. Long-term use of oral corticosteroids (OCS) is problematic because of…
View Post 3 min This content is machine translated Non-small cell lung cancer Platelets to predict immunotherapy response? Immunotherapy using checkpoint inhibitors has become an indispensable part of the treatment of non-small cell lung cancer. Nevertheless, there is room for improvement – and potential – in the area…
View Post 3 min This content is machine translated Non-small cell lung cancer Who benefits from targeted therapy? A large multicenter study led by the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim confirms substantial differences in treatment response and provides important insights for treatment planning.
View Post 4 min This content is machine translated Upper respiratory tract comorbidities When asthma and rhinosinusitis go hand in hand Almost half (45%) of all patients with – mainly severe – asthma are also affected by chronic rhinosinusitis with nasal polyps (CRSwNP). As many as 60% have allergic rhinitis as a…
